Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Return on Sales (2016 - 2025)

Historic Return on Sales for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to 0.15%.

  • Veracyte's Return on Sales rose 100.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.05% for FY2024, which is 2600.0% up from last year.
  • Veracyte's Return on Sales amounted to 0.15% in Q3 2025, which was up 100.0% from 0.01% recorded in Q2 2025.
  • In the past 5 years, Veracyte's Return on Sales ranged from a high of 0.15% in Q3 2025 and a low of 1.14% during Q1 2021
  • For the 5-year period, Veracyte's Return on Sales averaged around 0.14%, with its median value being 0.1% (2023).
  • Per our database at Business Quant, Veracyte's Return on Sales tumbled by -7600bps in 2021 and then skyrocketed by 9300bps in 2022.
  • Over the past 5 years, Veracyte's Return on Sales (Quarter) stood at 0.16% in 2021, then skyrocketed by 69bps to 0.05% in 2022, then crashed by -497bps to 0.29% in 2023, then surged by 115bps to 0.04% in 2024, then surged by 235bps to 0.15% in 2025.
  • Its Return on Sales stands at 0.15% for Q3 2025, versus 0.01% for Q2 2025 and 0.06% for Q1 2025.